Simplify Logo

Full-Time

Director – Biostatistics

Posted on 6/18/2024

Cytokinetics

Cytokinetics

201-500 employees

Develops drugs for muscle function improvement

Biotechnology
Healthcare

Compensation Overview

$198k - $242kAnnually

Senior, Expert

Villanova, PA, USA

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Master’s degree in statistics or biostatistics
  • 8+ years of biopharmaceutical statistics experience
  • Experience in late stage drug development, including phase IIb, phase III, and submissions in the pharmaceutical industry
  • Ability to communicate effectively within a multi-disciplinary project team
  • Experience in Biostatistics, SAS programming, and clinical data management in a regulated clinical research environment
  • Knowledge of missing data handling, multiple comparisons, and simulation techniques
  • Experience in organizing regulatory submissions such as BLA, NDA, sNDA, and MAA submissions
  • Good working knowledge of ICH, FDA and GCP regulations and guidelines
  • Strong leadership skills and teamwork spirit
  • Experience in the neurology/cardiovascular therapeutic areas
Responsibilities
  • Participate in strategic planning and develop optimal clinical development plans with cross-functional drug development teams
  • Oversee all the studies for one compound to ensure the consistency of statistical work standards as the project statistical leader
  • Responsible for writing statistical methodology section of the protocol, including sample size calculation
  • Responsible for writing statistical analysis plans (including mockup TLFs) for individual studies and ISS/ISE
  • Plan regulatory filings and ensure a timely submission with efficiency and accuracy in regulatory filing activities
  • Direct the activities of internal and external statistical programmers, to ensure the intended analyses are performed, and analysis data sets and their specifications are in place, following STDM standards
  • Review and comment on eCRFs, annotated eCRFs, edit checks documents and other clinical data management related documents
  • Participate in operations meetings, project team meetings, and address issues related to biostatistics
  • Support and participate in the preparation of study reports, regulatory submissions, and annual safety update reports
  • Perform ad hoc analysis and data validation
  • Develop and contribute to Biometrics SOPs and standard working documents meeting regulatory requirements throughout biometrics processes including IWRS/EDC, STDM, statistical programming for TLFs, and data reporting

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy (HCM) highlight the company's potential for market leadership in this area.
  • The $575M funding from Royalty Pharma ensures strong financial support for the commercial launch of aficamten and further R&D activities.
  • Recent investments and stock offerings indicate strong investor confidence and provide additional capital for growth and development.

What critics are saying

  • The late-stage biopharmaceutical market is highly competitive, with significant pressure to bring drugs to market quickly and efficiently.
  • Dependence on the success of clinical trials and regulatory approvals poses inherent risks, as any setbacks could delay commercialization and revenue generation.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle function improvement for cardiovascular and neuromuscular diseases, a niche area with high unmet medical needs.
  • The company has a robust pipeline of small molecule muscle activators and inhibitors, setting it apart from competitors with more generalized drug portfolios.
  • Strategic funding collaborations, such as the $575M deal with Royalty Pharma, provide significant financial backing for their R&D and commercialization efforts.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE